BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 3160802)

  • 1. Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro.
    Knepel W; Nutto D; Vlaskovska M; Kittel C
    J Endocrinol; 1985 Aug; 106(2):189-95. PubMed ID: 3160802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M; Hertting G; Knepel W
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prostaglandin E2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers.
    Knepel W; Götz D
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):149-55. PubMed ID: 3018594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of prostaglandin E2 and beta-endorphin-like immunoreactivity from rat adenohypophysis in vitro: variations after adrenalectomy or lesions of the paraventricular nuclei.
    Knepel W; Vlaskovska M; Meyer DK
    Brain Res; 1985 Feb; 326(1):87-94. PubMed ID: 3155985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prostaglandin synthesis and the release of vasopressin and oxytocin from the rat neurohypophysis: in vitro studies.
    Bojanowska E; Guzek JW
    Exp Clin Endocrinol; 1991; 98(3):213-21. PubMed ID: 1778241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway.
    Vlaskovska M; Knepel W
    Neuroendocrinology; 1984 Oct; 39(4):334-42. PubMed ID: 6092988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot shock stress-induced release of vasopressin in adenohypophysectomized and hypophysectomized rats.
    Knepel W; Przewlocki R; Nutto D; Herz A
    Endocrinology; 1985 Jul; 117(1):292-9. PubMed ID: 3159565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressin.
    Puurunen J; Leppäluoto J
    Eur J Pharmacol; 1984 Sep; 104(1-2):145-50. PubMed ID: 6094207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inhibitory and stimulative effects of prostaglandins on vasopressin-stimulated osmotic water flow in the toad bladder.
    Marumo F
    Jpn J Physiol; 1986; 36(5):935-44. PubMed ID: 3031349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
    Campbell WB; Gomez-Sanchez CE
    Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin release from rat medial basal hypothalamus in vitro after adrenalectomy or lesions of the paraventricular nuclei.
    Knepel W; Nutto D; Meyer DK; Vlaskovska M
    Neurosci Lett; 1984 Aug; 48(3):321-6. PubMed ID: 6091001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone increases vasopressin secretion from the neurointermediate lobe of the hypophysis of the rat: search for the endogenous agonist.
    Knepel W; Nutto D; Meyer DK
    Life Sci; 1983; 33 Suppl 1():499-502. PubMed ID: 6664231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin F2 alpha stimulates vasopressin and oxytocin release from isolated rat neurointermediate lobe.
    Bojanowska E; Guzek JW
    Exp Clin Endocrinol; 1989; 94(3):375-82. PubMed ID: 2630314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for prostaglandin F2 alpha, D2, E2 and thromboxane A2 in mediating the metabolic and hemodynamic actions of sympathetic nerves in perfused rat liver.
    Iwai M; Gardemann A; Püschel G; Jungermann K
    Eur J Biochem; 1988 Jul; 175(1):45-50. PubMed ID: 3165341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor.
    Altin JG; Bygrave FL
    Biochem J; 1988 Feb; 249(3):677-85. PubMed ID: 3128268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland.
    Lamberts SW; Bons EG; Uitterlinden P; Hackeng WH
    J Endocrinol; 1983 Mar; 96(3):395-400. PubMed ID: 6300274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prostaglandin E2 and D2 on the release of vasopressin and oxytocin.
    Hashimoto H; Noto T; Nakajima T
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):9-14. PubMed ID: 2740415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of indomethacin on responses of sheep isolated coronary artery to arachidonic acid.
    Cornish EJ; Goldie RG; Krstew EV; Miller RC
    Clin Exp Pharmacol Physiol; 1983; 10(2):171-5. PubMed ID: 6409479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro.
    Knepel W; Reimann W
    Brain Res; 1982 Apr; 238(2):484-8. PubMed ID: 6284302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.